Erman Akkuş
Impact in
-
- Diabetes Treatment and Management
-
- Cardiovascular Function and Risk Factors
- Cardiac electrophysiology and arrhythmias
Papers in
- Co-authors
- Belma Turan (2 shared papers)Aysegul Toy Durak (2 shared papers)Erkan Tuncay (3 shared papers)Yusuf Olğar (1 shared paper)Yüksel Ürün (4 shared papers)Mustafa Yaşar Şahin (3 shared papers)Güngör Utkan (6 shared papers)Çağatay Arslan (1 shared paper)
In The Last Decade
Erman Akkuş
27 papers receiving 308 citations
Peers
Comparison fields: 5 of 55
- Endocrinology, Diabetes and Metabolism 79
- Cardiology and Cardiovascular Medicine 54
- Clinical Biochemistry 12
- Hematology 19
- Molecular Biology 118
Countries citing papers authored by Erman Akkuş
This map shows the geographic impact of Erman Akkuş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erman Akkuş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erman Akkuş more than expected).
Fields of papers citing papers by Erman Akkuş
This network shows the impact of papers produced by Erman Akkuş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erman Akkuş. The network helps show where Erman Akkuş may publish in the future.
Co-authors
The 25 scholars most cited alongside Erman Akkuş, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 148 | |
| 2 | 2019 | 49 | |
| 3 | 2021 | 17 | |
| 4 | 2024 | 10 | |
| 5 | 2022 | 9 | |
| 6 | 2020 | 8 | |
| 7 | 2020 | 6 | |
| 8 | 2020 | 6 | |
| 9 | 2023 | 5 | |
| 10 | 2020 | 5 | |
| 11 | 2020 | 5 | |
| 12 | 2021 | 5 | |
| 13 | 2021 | 4 | |
| 14 | 2023 | 4 | |
| 15 | 2020 | 4 | |
| 16 | 2021 | 4 | |
| 17 | 2025 | 3 | |
| 18 | 2025 | 3 | |
| 19 | 2020 | 3 | |
| 20 | 2025 | 3 |
About Erman Akkuş
Erman Akkuş is a scholar working on Oncology, Surgery, Infectious Diseases, Hematology and Pulmonary and Respiratory Medicine, having authored 39 papers that have together received 312 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Colorectal Cancer Treatments and Studies (3 papers), COVID-19 Clinical Research Studies (2 papers), Multiple Myeloma Research and Treatments (2 papers), Lung Cancer Treatments and Mutations (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Inflammatory Biomarkers in Disease Prognosis (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (79 citations), Cardiology and Cardiovascular Medicine (54 citations), Clinical Biochemistry (12 citations), Hematology (19 citations) and Molecular Biology (118 citations). Erman Akkuş has collaborated with scholars based in Türkiye, Spain and Canada. Frequent co-authors include Belma Turan, Aysegul Toy Durak, Erkan Tuncay, Yusuf Olğar, Yüksel Ürün, Mustafa Yaşar Şahin, Güngör Utkan, Çağatay Arslan, Demet Çorapçıoğlu and Hamada Ahmed Mokhlis. Their work appears in journals such as Annals of Oncology, Cardiovascular Diabetology, Clinical Genitourinary Cancer, Critical Reviews in Oncology/Hematology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.